Title : CYP3A5*3 polymorphism and age affect tacrolimus blood trough concentration in myasthenia gravis patients.

Pub. Date : 2021 Jun 15

PMID : 33866281






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CYP3A5*3 polymorphism and age affect tacrolimus blood trough concentration in myasthenia gravis patients. Tacrolimus cytochrome P450 family 3 subfamily A member 5 Homo sapiens
2 Thus, CYP3A5*3 polymorphism and age should be considered in optimizing the initial dose of tacrolimus for MG treatment. Tacrolimus cytochrome P450 family 3 subfamily A member 5 Homo sapiens